Frankie L. Stinson

Array ( [id] => 8708586 [patent_doc_number] => 20130065875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'SMALL MOLECULE INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 13/504822 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21439 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10882551 [patent_doc_number] => 08906930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 13/511218 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36992 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6121024 [patent_doc_number] => 20110077233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'C-Met Modulators and Method of Use' [patent_app_type] => utility [patent_app_number] => 12/911442 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83739 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077233.pdf [firstpage_image] =>[orig_patent_app_number] => 12911442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973055 [patent_doc_number] => 20110152322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Aminopropenoates as Fungicides' [patent_app_type] => utility [patent_app_number] => 12/906491 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66749 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152322.pdf [firstpage_image] =>[orig_patent_app_number] => 12906491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413700 [patent_doc_number] => 08697737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Raf modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 12/903031 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93614 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12903031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937493 [patent_doc_number] => 08987301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/508090 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29406 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490543 [patent_doc_number] => 20110237610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Quinazoline Derivatives as Antiproliferative Agents' [patent_app_type] => utility [patent_app_number] => 12/902543 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36093 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237610.pdf [firstpage_image] =>[orig_patent_app_number] => 12902543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033851 [patent_doc_number] => 20110082289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Nucleic Acid Labeling Compounds' [patent_app_type] => utility [patent_app_number] => 12/892531 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12176 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082289.pdf [firstpage_image] =>[orig_patent_app_number] => 12892531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638180 [patent_doc_number] => 20130029983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'AMINOTHIENOPYRIDAZINE INHIBITORS OF TAU ASSEMBLY' [patent_app_type] => utility [patent_app_number] => 13/497697 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23633 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550739 [patent_doc_number] => 08063072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Heterocyclic antiviral compounds' [patent_app_type] => utility [patent_app_number] => 12/887450 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20982 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063072.pdf [firstpage_image] =>[orig_patent_app_number] => 12887450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892961 [patent_doc_number] => 08916574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => '4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/498547 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15149 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676954 [patent_doc_number] => 08815863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Compounds and therapeutic use thereof for protein kinase inhibition' [patent_app_type] => utility [patent_app_number] => 13/496494 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11372 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282924 [patent_doc_number] => 08217026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Substituted porphyrins' [patent_app_type] => utility [patent_app_number] => 12/885198 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13302 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12885198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977903 [patent_doc_number] => 20110071136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'NOVEL TRICYCLIC PROTEIN KINASE MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/883688 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26738 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071136.pdf [firstpage_image] =>[orig_patent_app_number] => 12883688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290326 [patent_doc_number] => 20120178622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Aminoquinazoline Compounds for Combating Invertebrate Pests' [patent_app_type] => utility [patent_app_number] => 13/497374 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51513 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290601 [patent_doc_number] => 20120178929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'METHOD FOR PREPARING HALOFUGINONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/496936 [patent_app_country] => US [patent_app_date] => 2010-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4853 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587375 [patent_doc_number] => 20110281885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/879885 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60139 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281885.pdf [firstpage_image] =>[orig_patent_app_number] => 12879885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264759 [patent_doc_number] => 20120164188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'PALIPERIDONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF IMPURITIES' [patent_app_type] => utility [patent_app_number] => 13/381716 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22146 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127235 [patent_doc_number] => 08575184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Quinazolines as potassium ion channel inhibitors' [patent_app_type] => utility [patent_app_number] => 13/393328 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 153665 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876354 [patent_doc_number] => 08901140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => '6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof' [patent_app_type] => utility [patent_app_number] => 13/395892 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15429 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395892 [rel_patent_id] =>[rel_patent_doc_number] =>)